Literature DB >> 19882737

Protein disulfide isomerase does not control recombinant IgG4 productivity in mammalian cell lines.

N V L Hayes1, C M Smales, P Klappa.   

Abstract

Post-translational limitations in the endoplasmic reticulum during recombinant monoclonal antibody production are an important factor in lowering the capacity for synthesis and secretion of correctly folded proteins. Mammalian protein disulfide isomerase (PDI) has previously been shown to have a role in the formation of disulfide bonds in immunoglobulins. Several attempts have been made to improve the rate of recombinant protein production by overexpressing PDI but the results from these studies have been inconclusive. Here we examine the effect of (a) transiently silencing PDI mRNA and (b) increasing the intracellular levels of members of the PDI family (PDI, ERp72, and PDIp) on the mRNA levels, assembly and secretion of an IgG4 isotype. Although transiently silencing PDI in NS0/2N2 cells suggests that PDI is involved in disulfide bond formation of this subclass of antibody, our results show that PDI does not control the overall IgG4 productivity. Furthermore, overexpression of members of the PDI family in a Chinese hamster ovary (CHO) cell line does not improve productivity and hence we conclude that the catalysis of disulfide bond formation is not rate limiting for IgG4 production. (c) 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19882737     DOI: 10.1002/bit.22587

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  8 in total

1.  IgG Aggregation Mechanism for CHO Cell Lines Expressing Excess Heavy Chains.

Authors:  Steven C L Ho; Tianhua Wang; Zhiwei Song; Yuansheng Yang
Journal:  Mol Biotechnol       Date:  2015-07       Impact factor: 2.695

2.  Modulation of phosducin-like protein 3 (PhLP3) levels promotes cytoskeletal remodelling in a MAPK and RhoA-dependent manner.

Authors:  Nandini V L Hayes; Lyne Jossé; C Mark Smales; Martin J Carden
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

3.  Effect of Cysteamine on Cell Growth and IgG4 Production in Recombinant Sp2.0 Cells.

Authors:  Hoda Jahandar; Behrouz Vaziri; Leila Nematollahi; Tayebeh Afsharirad; Esmat Mirabzadeh; Fatemeh Torkashvand; Vahid Khalaj
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

4.  A cross-species whole genome siRNA screen in suspension-cultured Chinese hamster ovary cells identifies novel engineering targets.

Authors:  Gerald Klanert; Daniel J Fernandez; Marcus Weinguny; Peter Eisenhut; Eugen Bühler; Michael Melcher; Steven A Titus; Andreas B Diendorfer; Elisabeth Gludovacz; Vaibhav Jadhav; Su Xiao; Beate Stern; Madhu Lal; Joseph Shiloach; Nicole Borth
Journal:  Sci Rep       Date:  2019-06-18       Impact factor: 4.996

Review 5.  Thiol Modifications in the Extracellular Space-Key Proteins in Inflammation and Viral Infection.

Authors:  Kathrin A Brücksken; Paola Loreto Palacio; Eva-Maria Hanschmann
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

6.  Experimental and in silico modelling analyses of the gene expression pathway for recombinant antibody and by-product production in NS0 cell lines.

Authors:  Emma J Mead; Lesley M Chiverton; Sarah K Spurgeon; Elaine B Martin; Gary A Montague; C Mark Smales; Tobias von der Haar
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

7.  Quantitative definition and monitoring of the host cell protein proteome using iTRAQ - a study of an industrial mAb producing CHO-S cell line.

Authors:  Lesley M Chiverton; Caroline Evans; Jagroop Pandhal; Andrew R Landels; Byron J Rees; Peter R Levison; Phillip C Wright; C Mark Smales
Journal:  Biotechnol J       Date:  2016-06-22       Impact factor: 4.677

8.  Overexpression of transcription factor Foxa1 and target genes remediate therapeutic protein production bottlenecks in Chinese hamster ovary cells.

Authors:  Audrey Berger; Valérie Le Fourn; Jacqueline Masternak; Alexandre Regamey; Iris Bodenmann; Pierre-Alain Girod; Nicolas Mermod
Journal:  Biotechnol Bioeng       Date:  2020-02-23       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.